James Woodward
Mr. Woodward has spent over 25 years in early-stage medical device, diagnostic, and healthcare service companies with strong experience in financial direction, general management, M&A/licensing, and product development strategy. He was most recently President & CEO of Encelle Inc., a venture-backed developer of tissue-regenerative biopolymers, acquired by Pioneer Surgical Technology (PST) in 2007. Prior to joining TCG, he had been consulting with PST in outlicensing the Encelle technologies outside of orthopedics and spine, completing licenses for cosmetic surgery, and animal health applications.
Earlier, Mr. Woodward was also a Co-founder, Director, and acting CFO in the early years of
Accordant Health Services (a provider of chronic disease management services). He also served as acting Chairman & CEO of Aprex Corporation (an international producer of medication compliance and monitoring devices). In that role, he hired new management, redirected strategy, and secured financing. Concurrently, he was General Manager of Intella Systems, a start-up developing deflectable tip coronary catheters and guide wires. Before Intella, Mr.
Woodward had been President & CEO of Cardiometrics, a maker of invasive blood flow measuring devices.
Also in California, Mr. Woodward was CFO and Director of Advanced Cardiovascular Systems, Inc., the second company to market coronary angioplasty catheters (acquired by Eli Lilly and later part of Guidant Corporation). He was a Co-founder and Director of Interventional
Technologies and Ventana Medical Systems.
Mr. Woodward began his business career as a management consultant with McKinsey & Company working in Dallas, Amsterdam, San Francisco and Sydney. He served in the Navy on a nuclear submarine and holds an A.B. in economics from Princeton University and an M.B.A. from Stanford University Graduate School of Business.
